RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
Last trade$353.35
Day change-$3.245 (-0.91%)
Day range$352.12 – $356.59
Volume118,207
Market cap$14.41B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$14.41B
Price / earnings
9.6×
Price / book
1.27×
Price / sales
1.5×
EV / sales
1.62×
EV / EBITDA
5.33×
Profitability
Earnings per share
$37.13
Return on assets
2.74%
Return on equity
13.21%
Dividend yield
0.73%
Liquidity and leverage
Debt / equity
0.21×
Current ratio
1.03×
Quick ratio
1.03×
Cash ratio
0.12×
Cash flow
Price / cash flow
5.11×
Price / free cash flow
6.7×
Free cash flow
$2.15B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for RNR, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$1.69B
$2.77B
$2.19B
$2.97B
$3.2B
$3.21B
$3.47B
$2.29B
Cost of revenue
$1.57B
$1.51B
$1.51B
$1.55B
$1.54B
$1.68B
$3.39B
$2.16B
Gross profit
$122.09M
$1.26B
$689.1M
$1.42B
$1.66B
$1.52B
$79.3M
$131.52M
Selling, general and administrative
$16.69M
$18.68M
$19.46M
$12M
$23.41M
$23.78M
$22.81M
$34.3M
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$1.69B
$1.62B
$1.61B
$1.68B
$1.69B
$1.83B
$3.51B
$2.35B
Operating income
-$200K
$1.15B
$580.6M
$1.3B
$1.51B
$1.37B
-$43.7M
-$59.88M
Interest expense
-$31.79M
-$31.78M
-$31.79M
-$31.39M
-$30.58M
-$31.79M
-$27.09M
-$23.25M
Income before taxes
-$31.99M
$1.12B
$548.81M
$1.26B
$1.48B
$1.34B
-$70.79M
-$83.13M
Income taxes
-$30.15M
$139.4M
$32.98M
$116.13M
$148.86M
$176.87M
-$45.53M
-$63.91M
Net income
-$1.84M
$978.34M
$515.83M
$1.15B
$1.33B
$1.16B
-$25.26M
-$19.22M
Net income attributable to common shareholders
-$162.01M
$643.17M
$279.96M
$739.12M
$892.65M
$813.16M
$158.78M
-$195.93M
EBITDA
-$25.62M
$1.13B
$556.24M
$1.28B
$1.5B
$1.38B
-$39.97M
-$53.04M
Basic earnings per share
-$4.02
$15.54
$6.60
$16.82
$19.47
$17.25
$3.29
-$3.89
Diluted earnings per share
-$4.02
$15.48
$6.57
$16.75
$19.40
$17.20
$3.27
-$3.87
Recent news
Company coverage with links to the original publishers.
RenaissanceRe reported $513 million in operating income for Q3 2026, driven by higher market yields (6% weighted average yield to maturity) and disciplined capital allocation. The company is focusing on high-margin property catastrophe coverage while reducing casualty exposure, and has expanded ceded reinsurance to protect profitability. Management expects the property business to remain rate adequate with returns exceeding cost of capital.
As AI sector weakness prompts defensive positioning, Zacks highlights three stocks offering diversification: American Healthcare REIT (healthcare real estate with demographic tailwinds), Cheniere Energy (LNG exporter benefiting from geopolitical demand), and RenaissanceRe (insurance company gaining from higher interest rates). All three have strong earnings revisions and Zacks Rank ratings.
As AI and semiconductor sectors face correction and the Fed resumes interest rate hikes, investors are advised to diversify into defensive sectors. Three recommended stocks are American Healthcare REIT (healthcare/financials), Cheniere Energy (energy), and RenaissanceRe (insurance), all showing strong fundamentals, positive earnings revisions, and limited AI exposure.
Accelerant Holdings (ARX) is set to report Q3 2026 results on Nov. 12 with consensus EPS estimates of 20 cents (down 47.4% YoY) and revenues of $270.94M (up 1.3% YoY). While net earned premiums and investment income are expected to grow, adjusted EBITDA is projected to decline significantly in Underwriting (79.9%) and MGA (52%) segments. The company has an Earnings ESP of 0.00% and Zacks Rank #4, suggesting no conclusive earnings beat expected.
RenaissanceRe (RNR) has earned a Zacks Momentum Style Score of A and a #2 (Buy) rating. The insurance company demonstrates strong short-term and long-term price performance, outperforming its industry and the S&P 500. Recent earnings estimate revisions have been positive, with 7 upward revisions and none downward over the past two months, boosting consensus estimates from $42.57 to $49.24.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.41 per share
Declared
Nov 11, 2026
Ex-dividend
Dec 15, 2026
Pay date
Dec 31, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 15, 2026
$0.41
Sep 30, 2026
recurring
Jun 15, 2026
$0.41
Jun 30, 2026
recurring
Mar 13, 2026
$0.41
Mar 31, 2026
recurring
Dec 15, 2025
$0.40
Dec 31, 2025
recurring
Sep 15, 2025
$0.40
Sep 30, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.